Fahad Muflih AlShagathrh

Mr. Fahad Muflih AlShagathrh

Hamad bin Khalifa University, Doha, Ad Dawḩah, Qatar
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2022 in Bioengineering
Verified
Journal Article
Open access
PDF file
FAFahad Muflih AlShagathrh
Fahad Muflih AlShagathrh
MHMowafa Househ
Mowafa Househ
Background: Non-alcoholic Fatty Liver Disease (NAFLD) is growing more prevalent worldwide. Although non-invasive diagnostic approaches such as conventional ultrasonography and clinical scoring systems have been proposed as alternatives to liver biopsy, their efficacy has been called into doubt. Artificial Intelligence (AI) is now combined with traditional diagnostic processes to improve the performance of non-invasive approaches. Objective: This study explores how well various AI methods function and perform on ultrasound (US) images to diagnose and quantify non-alcoholic fatty liver disease. Methodology: A systematic review was conducted to achieve this objective. Five science bibliographic databases were searched, including PubMed, Association for Computing Machinery ACM Digital Library, Institute of Electrical and Electronics Engineers IEEE Xplore, Scopus, and Google Scholar. Only peer-reviewed English articles, conferences, theses, and book chapters were included. Data from studies were synthesized using narrative methodologies per Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria. Results: Forty-nine studies were included in the systematic review. According to the qualitative analysis, AI significantly enhanced the diagnosis of NAFLD, Non-Alcoholic Steatohepatitis (NASH), and liver fibrosis. In addition, modalities, image acquisition, feature extraction and selection, data management, and classifiers were assessed and compared in terms of performance measures (i.e., accuracy, sensitivity, and specificity). Conclusion: AI-supported systems show potential performance increases in detecting and quantifying steatosis, NASH, and liver fibrosis in NAFLD patients. Before real-world implementation, prospective studies with direct comparisons of AI-assisted modalities and conventional techniques are necessary.

1 October 2018 in International Journal of Medical Informatics
Verified
Journal Article
Closed access
FAFahad Muflih AlShagathrh
Fahad Muflih AlShagathrh
SKSAMINA AMANULLAH KHAN
SAMINA AMANULLAH KHAN
NANazeeh Alothmany
Nazeeh Alothmany
Nedal Al-RawashdehNedal Al-Rawashdeh
Nedal Al-Rawashdeh
MHMowafa Househ
Mowafa Househ

24 November 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
FAFahad Muflih AlShagathrh
Fahad Muflih AlShagathrh
MAMahmood Alzubaidi
Mahmood Alzubaidi
SGSamuel Gecík
Samuel Gecík
KAKhalid A Alswat
Khalid A Alswat
AAAli Aldhebaib
Ali Aldhebaib
MHMowafa Househ
Mowafa Househ
Background: Hepatocyte ballooning (HB) is a significant histological characteristic linked to the advancement of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Although clinicians now consider liver biopsy the most reliable method for identifying HB, its invasive nature and related dangers highlight the need for the development of non-invasive diagnostic options. Objective: This study aims to develop a novel methodology that combines deep learning and machine learning techniques to accurately identify and measure hepatobiliary abnormalities in liver ultrasound images. Methods: The research team expanded the dataset, consisting of ultrasound images, and used it for training deep convolutional neural networks (CNNs) such as InceptionV3, ResNet50, DenseNet121, and EfficientNetB0. A hybrid approach, combining InceptionV3 for feature extraction with a Random Forest classifier, emerged as the most accurate and stable method. An approach of dual dichotomy classification was used to categorize images into two stages: healthy vs. sick, and then mild versus severe ballooning.. Features obtained from CNNs were integrated with conventional machine learning classifiers like Random Forest and Support Vector Machines (SVM). Results: The hybrid approach achieved an accuracy of 97.40%, an area under the curve (AUC) of 0.99, and a sensitivity of 99% for the ‘Many’ class during the third phase of evaluation. The dual dichotomy classification enhanced the sensitivity in identifying severe instances of HB. The cross-validation process confirmed the strength and reliability of the suggested models. Conclusions: These results indicate that this combination method can decrease the need for invasive liver biopsies by providing a non-invasive and precise alternative for early identification and monitoring of NAFLD and NASH. Subsequent research will prioritize the validation of these models using larger datasets from multiple centers to evaluate their generalizability and incorporation into clinical practice.

27 December 2024 in Data in Brief
Verified
Journal Article
Open access
FAFahad Muflih AlShagathrh
Fahad Muflih AlShagathrh
MAMahmood Alzubaidi
Mahmood Alzubaidi
KAKhalid A Alswat
Khalid A Alswat
AAAli Aldhebaib
Ali Aldhebaib
BABushra Al Ahmadi
Bushra Al Ahmadi
MHMowafa Househ
Mowafa Househ
This study presents a comprehensive ultrasound image dataset for Non-Alcoholic Fatty Liver Disease (NAFLD), addressing the critical need for standardized resources in AI-assisted diagnosis. The dataset comprises 10,352 high-resolution ultrasound images from 384 patients collected at King Saud University Medical City and National Guard Health Affairs in Saudi Arabia. Each image is meticulously annotated with NAFLD Activity Score (NAS) fibrosis staging and steatosis grading based on corresponding liver biopsy results. Unlike other datasets that rely on bounding boxes, we opted for full-image labelling based on biopsy findings, which link to histopathological results, ensuring more precise representation of liver conditions. Rigorous pre-processing ensures high-quality image preservation, including expert radiologist assessment, DICOM to PNG conversion, and standardization to 768 × 1024 pixels. This resource supports various computer vision tasks, enabling the development of AI algorithms for accurate NAFLD diagnosis and staging. A large, diverse, and well-annotated dataset like ours is essential for enhancing model performance and generalization, providing a valuable resource for researchers to develop robust AI models in medical imaging.

30 October 2023 in Traitement du Signal
Verified
Journal Article
Closed access
FAFahad Muflih AlShagathrh
Fahad Muflih AlShagathrh
SMSaleh Musleh
Saleh Musleh
MAMahmood Alzubaidi
Mahmood Alzubaidi
JSJens Schneider
Jens Schneider
MHMowafa S. Househ
Mowafa S. Househ

6 October 2025 in IEEE Access
Verified
Journal Article
Open access
FAFahad Muflih AlShagathrh
Fahad Muflih AlShagathrh
HZHaider Dhia Zubaydi
Haider Dhia Zubaydi
MAMahmood Alzubaidi
Mahmood Alzubaidi
AAAbdulaziz Alosaimi
Abdulaziz Alosaimi
RSRaneem Mohammed Al Saqer
Raneem Mohammed Al Saqer
MHMowafa Househ
Mowafa Househ
Non-alcoholic fatty liver disease (NAFLD) is a growing public health challenge, underscoring the need for scalable, non-invasive tools to grade hepatic steatosis. Although B-mode ultrasound is accessible and safe, its reliability is limited by operator and scanner variability. We present the Deep Domain Adaptation Neural Network (DDANN), a deep learning system for multiclass steatosis classification (Normal, Mild, Moderate, Severe) from ultrasound that emphasizes cross-device generalizability. To mitigate distribution shifts across scanners (LOGIQ, iU22, EPIQ), DDANN combines a MobileNetV2 backbone with triplet loss, entropy-based domain adaptation, and preprocessing that includes speckle suppression, percentile normalization, and LOGIQ-specific harmonization. Trained on a biopsy-confirmed, multi-institutional cohort (primarily LOGIQ and iU22), the model was externally validated on an unseen EPIQ test set of 1,083 images from 47 patients, achieving 98.71% accuracy, 0.9872 macro F1-score, and 0.9998 AUC-ROC, outperforming baselines. In a separate radiologist–AI comparison on 224 biopsy-confirmed images not used for training or validation, the AI reached 91.96% accuracy, significantly exceeding radiologists’ 19.64%–31.70% (McNemar’s test, p < 0.001), with strong agreement to ground truth (κ = 0.893) versus radiologists’ poor-to-slight agreement (κ = 0.006–0.194). The AI maintained balanced class-wise F1-scores (0.90–0.94), while radiologists struggled, particularly with Mild and Moderate cases, and exhibited substantial inter-reader variability (κ = 0.068–0.648). These results demonstrate robust cross-device performance and support integrating AI as a reliable second reader or primary screening tool to reduce subjectivity in steatosis assessment.